LegoChem Financial Statements From 2010 to 2024

141080 Stock  KRW 95,500  3,900  3.92%   
LegoChem Biosciences financial statements provide useful quarterly and yearly information to potential LegoChem Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on LegoChem Biosciences financial statements helps investors assess LegoChem Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting LegoChem Biosciences' valuation are summarized below:
LegoChem Biosciences does not presently have any fundamental ratios for analysis.
Check LegoChem Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LegoChem Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . LegoChem financial statements analysis is a perfect complement when working with LegoChem Biosciences Valuation or Volatility modules.
  
This module can also supplement various LegoChem Biosciences Technical models . Check out the analysis of LegoChem Biosciences Correlation against competitors.

LegoChem Biosciences Company Current Valuation Analysis

LegoChem Biosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current LegoChem Biosciences Current Valuation

    
  1.09 T  
Most of LegoChem Biosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LegoChem Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, LegoChem Biosciences has a Current Valuation of 1.09 T. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

LegoChem Biosciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining LegoChem Biosciences's current stock value. Our valuation model uses many indicators to compare LegoChem Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LegoChem Biosciences competition to find correlations between indicators driving LegoChem Biosciences's intrinsic value. More Info.
LegoChem Biosciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value LegoChem Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LegoChem Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About LegoChem Biosciences Financial Statements

LegoChem Biosciences stakeholders use historical fundamental indicators, such as LegoChem Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although LegoChem Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in LegoChem Biosciences' assets and liabilities are reflected in the revenues and expenses on LegoChem Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LegoChem Biosciences. Please read more on our technical analysis and fundamental analysis pages.
LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and ADC platform. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea. LegoChem Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with LegoChem Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LegoChem Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LegoChem Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving against LegoChem Stock

  0.74029780 Samsung CardPairCorr
  0.62215600 SillaJenPairCorr
The ability to find closely correlated positions to LegoChem Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LegoChem Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LegoChem Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LegoChem Biosciences to buy it.
The correlation of LegoChem Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LegoChem Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LegoChem Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LegoChem Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in LegoChem Stock

LegoChem Biosciences financial ratios help investors to determine whether LegoChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LegoChem with respect to the benefits of owning LegoChem Biosciences security.